Back to Search
Start Over
Altamira Therapeutics Announce Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
- Source :
- Plus Company Updates. May 2, 2024
- Publication Year :
- 2024
-
Abstract
- HAMILTON: Altamira Therapeutics Ltd. ('Altamira' or the 'Company') (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that it has filed [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.795976845